
|Videos|December 29, 2022
Adverse Events Tied to Treatment for Myeloproliferative Neoplasms
Author(s)Ruben Mesa, M.D., Rami S. Komrokji, M.D.
Expert perspectives on the possible adverse events patients may encounter while receiving treatment for myeloproliferative neoplasms.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Grants Orphan Drug Designation to MNV-201 for Myelodysplastic Syndrome
2
A Survivor's 30-Year Wait for Lymphedema Relief Ends with Hackensack's New Supermicrosurgery Robotic Procedure
3
What Breast Cancer Awareness Means to Me as a 23-Year Survivor
4
Jakafi Trial Shows Benefits for Patients with Myelofibrosis and Anemia
5